VIVS Earnings Date: Nov 5, 2026 (Estimated) — VivoSim Labs, Inc.
NASDAQ
Updated
When is VIVS's next earnings date?
VivoSim Labs, Inc. (VIVS) is expected to report Q2 2027 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company.
How did VIVS do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q1 2027), VivoSim Labs, Inc. posted EPS of -$0.25. Revenue was $18,000. The stock's 1-day post-earnings move was -1.2%.
How much does VIVS stock move after earnings?
VIVS beat EPS estimates in 3 of its last 3 reported quarters. Over the last 8 reports the stock moved an average of 3.4% (up or down) in the day after earnings.
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q1 2027 | — | -0.25 | — | $18,000 | — | -1.20% | -16.50% | -14.75% |
| 2026-07-14 | Q4 2026 | — | -2.21 | — | $40,000 | — | +2.17% | -46.09% | -60.22% |
| 2025-11-06 | Q2 2026 | — | -0.98 | — | $28,000 | — | -0.46% | -2.28% | +9.13% |
| 2025-08-12 | Q1 2026 | — | -1.14 | — | $37,000 | — | +6.05% | +2.63% | +110.67% |
| 2024-11-08 | Q2 2025 | -3.12 | -1.68 | +46.15% | $30,000 | ✅ Beat | -0.64% | +4.07% | +4.57% |
| 2024-05-31 | Q4 2024 | -5.04 | -3.48 | +30.95% | $29,000 | ✅ Beat | +5.76% | -2.37% | -23.73% |
| 2024-02-08 | Q3 2024 | -6.00 | -4.80 | +20.00% | $5,000 | ✅ Beat | -10.00% | +2.00% | +1.00% |
| 2023-08-10 | Q1 2024 | — | -5.52 | — | $75,000 | — | -0.63% | -8.80% | -33.33% |
Showing last 8 quarters.